Sanaria Inc.
Sumana Chakravarty, PhD, is an experienced professional who has held various leadership roles in the field of immunology and model systems. With an extensive background in molecular biology, Sumana has worked at reputable organizations such as Sanaria Inc., Johns Hopkins Bloomberg School of Public Health, and the National Institutes of Health. With a strong academic foundation from Tata Institute of Fundamental Research in Mumbai, India, Sumana continues to make significant contributions to the field of vaccine extraction and cellular immunology.
Sanaria Inc.
Sanaria is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Sanaria’s vaccine is based on an approach to immunization that has already proven highly protective in humans.